Funding for this research was provided by:
Japan Agency for Medical Research and Development (18lk0310044h0001)
Received: 6 September 2019
Accepted: 5 May 2020
First Online: 16 June 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all patients or their families. The study was approved by the Central Review Board of Kanazawa University Hospital, and the study was conducted in accordance with the ethical standards of the Declaration of Helsinki.
: Not applicable.
: The study drug was received from Tsumura Co. The company has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.